Erythrocyte membrane phosphorylation in untreated and in etretinate-treated psoriatic patients.
Levels of phosphorylation were decreased in bands 2 to 2.1, 2.9 to 3 and 4.5 to 4.8 of erythrocyte membranes from psoriatic patients compared with control values. In addition, higher than control levels of 32P were incorporated into a new polypeptide band (mol.wt. 18-20,000 daltons) of red cell membranes from patients. Uptake of 32P by these bands returned towards normal after the patients received oral etretinate treatment. These results suggest there is a generalized plasma membrane defect in psoriasis and that etretinate may affect the metabolism of red cell membrane proteins.